34 related articles for article (PubMed ID: 32164493)
1. Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment.
Alsdorf WH; Karagiannis P; Langebrake C; Bokemeyer C; Frenzel C
Oncologist; 2021 Feb; 26(2):e327-e332. PubMed ID: 33215763
[TBL] [Abstract][Full Text] [Related]
2. Sodium bicarbonate to prevent cardiac surgery-associated kidney injury: the end of a dream?
Hougardy JM; De Backer D
Crit Care; 2012 Dec; 16(6):186. PubMed ID: 23234469
[TBL] [Abstract][Full Text] [Related]
3. Acetazolamide for acute kidney injury in patients undergoing high dose methotrexate therapy: a systematic review and meta-analysis.
Truong HH; Reddy S; Charkviani M; Nikravangolsefid N; Ninan J; Hassett L; Kashani KB; Domecq JP
J Nephrol; 2024 Jan; ():. PubMed ID: 38265601
[TBL] [Abstract][Full Text] [Related]
4. Stability of lidocaine solutions following sodium bicarbonate alkalinization.
Hyuga S; Tomoda Y; Okutomi T
Reg Anesth Pain Med; 2022 Jul; ():. PubMed ID: 35858719
[No Abstract] [Full Text] [Related]
5. Assessing the impact of adding acetazolamide to oral or intravenous sodium bicarbonate as compared with intravenous bicarbonate monotherapy as urinary alkalinization in adults receiving high-dose methotrexate.
Clemmons AB; Chase A; Duong P; Waller JL; Saunders K; Bryan L
Support Care Cancer; 2021 Mar; 29(3):1527-1534. PubMed ID: 32725375
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate osteopathy: five cases and systematic literature review.
Robin F; Cadiou S; Albert JD; Bart G; Coiffier G; Guggenbuhl P
Osteoporos Int; 2021 Feb; 32(2):225-232. PubMed ID: 33128074
[TBL] [Abstract][Full Text] [Related]
7. What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning?
Chan BS; Dawson AH; Buckley NA
Clin Toxicol (Phila); 2017 Feb; 55(2):88-96. PubMed ID: 28084171
[TBL] [Abstract][Full Text] [Related]
8. Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis.
Kaveh-Ahangaran R; Abdollahi M; Vaezi M; Kasaeian A; Bahlouli Z; Janbabaei G; Mojtahedzadeh A; Mojtahedzadeh M; Djalalinia S; Shahrami B
Daru; 2024 Jun; 32(1):353-377. PubMed ID: 38233724
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of methotrexate clearance with an enteral urine alkalinization protocol for patients receiving high-dose methotrexate.
Kramer E; Filtz M; Pace M
J Oncol Pharm Pract; 2021 Jan; 27(1):26-32. PubMed ID: 32164493
[TBL] [Abstract][Full Text] [Related]
10. Comparison of enteral and parenteral methods of urine alkalinization in patients receiving high-dose methotrexate.
Rouch JA; Burton B; Dabb A; Brown V; Seung AH; Kinsman K; Holdhoff M
J Oncol Pharm Pract; 2017 Jan; 23(1):3-9. PubMed ID: 26467268
[TBL] [Abstract][Full Text] [Related]
11. Oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization: A pediatric experience.
Diachinsky M; Tran T; Jupp J; McKinnon K
J Oncol Pharm Pract; 2021 Jan; 27(1):119-127. PubMed ID: 32316877
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of a urine alkalinization protocol developed for high-dose methotrexate patients during intravenous bicarbonate shortage.
Roy AM; Lei M; Lou U
J Oncol Pharm Pract; 2019 Dec; 25(8):1860-1866. PubMed ID: 30636529
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
